publication venue for
- Comparison of FDG and FMISO uptakes and distributions in head and neck squamous cell cancer tumors.. 11. 2021
- Fluorescence labeling of a NaV1.7-targeted peptide for near-infrared nerve visualization.. 10. 2020
- A near-infrared probe for non-invasively monitoring cerebrospinal fluid flow by 18F-positron emitting tomography and fluorescence.. 10. 2020
- Molecular imaging of endothelial activation and mineralization in a mouse model of accelerated atherosclerosis.. 9. 2019
- Leveraging PET to image folate receptor α therapy of an antibody-drug conjugate.. 8. 2018
- Discriminating radiation injury from recurrent tumor with [18F]PARPi and amino acid PET in mouse models.. 8. 2018
- Pretargeting of internalizing trastuzumab and cetuximab with a 18F-tetrazine tracer in xenograft models.. 7. 2017
- A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB-IIIA resectable NSCLC.. 7. 2017
- Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer.. 6. 2016
- Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide.. 6. 2016
- Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modeling.. 6. 2016
- Radioiodinated PARP1 tracers for glioblastoma imaging.. 5. 2015
- Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors.. 5. 2015
- Pilot study of PET imaging of 124I-iodoazomycin galactopyranoside (IAZGP), a putative hypoxia imaging agent, in patients with colorectal cancer and head and neck cancer.. 3. 2013